SchaafEAFieldingSLWesthoffCEllertsonCEisengerSHStadaliusLSVaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial. JAMA2000;284: 1948–53.
2.
UlmannABarnardJ. Termination of pregnancy with mifepristone (letter). Br Med J1993;307:684.
3.
HillNCFergusonJMacKenzieIZ. The efficacy of oral mifepristone (RU 38,486) with a prostaglandin E1 analogs and vaginal pessary for the termination of early pregnancy: Complications and patient acceptability. Am J Obstet Gynecol1990;162:414–7.
4.
SpitzIMBardinCWBentonRobbinsA. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med1998;338:1241–7.
5.
DavisAWesthoffCDe NonnoL. Bleeding patterns after early abortion with mifepristone and misoprostol or manual vacuum aspiration. J Am Med Womens Assoc2000;55(3 suppl):141–4.
6.
Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor. Science1989;245:1355.
7.
PerduMCamusERozenbergPGoffinetFChastangCPhilippeHJNisandI. Treating ectopic pregnancy with the combination of mifepristone and methotrexate: A Phase II nonrandomized study. Am J Obstet Gynecol1998;179(3 pt 1):640–3.
8.
PonsJCImbertMCElefantERouxCHerschkornPPapiernikE. Development after exposure to mifepristone in early pregnancy (letter). Lancet1991;338:763.
9.
UlmannARubinIBarnardJ. Development after in-utero exposure to mifepristone (letter). Lancet1991;338:1270.
10.
The informed consent document used in France for RU 486. In: RU 486: The science and the politics. New York: Alan Guttmacher Institute, 1989:8.
11.
SchonhofarP. Brazil: Misuse of misoprostol as an abortifacient may induce malformations. Lancet1991;337:1534–5.
12.
Package insert. Mifeprex (mifepristone). Chicago: Searle, August 23, 2000.
13.
CullenM. Important drug warning concerning unapproved use of intravaginal or oral misoprostol in pregnant women for induction of labor or abortion (open letter). Skokie, IL, August 23, 2000.
